Sarclisa यूरोपीय संघ - क्रोएशियाई - EMA (European Medicines Agency)

sarclisa

sanofi winthrop industrie - isatuximab - multipli mijelom - antineoplastična sredstva - sarclisa is indicated: in combination with pomalidomide and dexamethasone, for the treatment of adult patients with relapsed and refractory multiple myeloma (mm) who have received at least two prior therapies including lenalidomide and a proteasome inhibitor (pi) and have demonstrated disease progression on the last therapy. in combination with carfilzomib and dexamethasone, for the treatment of adult patients with multiple myeloma who have received at least one prior therapy (see section 5.

OGIVRI 420mg Prašak za koncentrat za rastvor za infuziju मोंटेनेग्रो - क्रोएशियाई - CInMED-Institut za ljekove i medicinska sredstva Crne Gore

ogivri 420mg prašak za koncentrat za rastvor za infuziju

druŠtvo za trgovinu na veliko farmaceutskim proizvodima "glosarij" d.o.o.-podgorica - trastuzumab - prašak za koncentrat za rastvor za infuziju - 420mg